Atricure Inc. buy Needham & Company LLC
Start price
16.02.24
/
50%
€28.89
Target price
16.02.25
€42.79
Performance (%)
-
End price
17.02.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Atricure Inc. | -2.439% | -2.439% | -52.266% |
iShares Core DAX® | 3.900% | 3.645% | 27.100% |
iShares Nasdaq 100 | 1.567% | 6.505% | 18.942% |
iShares Nikkei 225® | 0.653% | 8.282% | 9.572% |
iShares S&P 500 | 1.209% | 4.118% | 12.123% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at Needham & Company LLC from $44.00 to $46.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten